Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely?

In This Article:

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?

So, the natural question for Generation Bio (NASDAQ:GBIO) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'.

See our latest analysis for Generation Bio

When Might Generation Bio Run Out Of Money?

A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at September 2024, Generation Bio had cash of US$185m and no debt. Looking at the last year, the company burnt through US$104m. So it had a cash runway of approximately 21 months from September 2024. While that cash runway isn't too concerning, sensible holders would be peering into the distance, and considering what happens if the company runs out of cash. The image below shows how its cash balance has been changing over the last few years.

debt-equity-history-analysis
NasdaqGS:GBIO Debt to Equity History January 16th 2025

How Well Is Generation Bio Growing?

Generation Bio boosted investment sharply in the last year, with cash burn ramping by 92%. But shareholders are no doubt taking some confidence from the rockstar revenue growth of 514% during that same year. On balance, we'd say the company is improving over time. While the past is always worth studying, it is the future that matters most of all. So you might want to take a peek at how much the company is expected to grow in the next few years.

Can Generation Bio Raise More Cash Easily?

While Generation Bio seems to be in a fairly good position, it's still worth considering how easily it could raise more cash, even just to fuel faster growth. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Many companies end up issuing new shares to fund future growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.